Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT

Ernestina M De Francesco1,2, Marcello Maggiolini3, Anna Maria Musti4

  • 1Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy. ernestina.defrancesco@manchester.ac.uk.

Insights

The Notch pathway, influenced by hypoxia and estrogen, drives epithelial-mesenchymal-transition (EMT) in breast cancer. Targeting this network may offer new therapeutic strategies for cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The Notch signaling pathway is crucial in development and cancer, regulating processes like angiogenesis and epithelial-mesenchymal-transition (EMT).
  • EMT involves epithelial cells losing differentiation and gaining motility, contributing to cancer progression, often influenced by genetic instability or the tumor microenvironment.

Purpose of the Study:

  • To explore the functional interactions between Notch signaling, hypoxia, and estrogen in breast cancer cells, focusing on EMT.
  • To investigate the role of hypoxia signaling and the interaction between HIF-1α and GPER in breast cancer cells and cancer-associated fibroblasts (CAFs).

Main Methods:

  • Review of studies on Notch signaling pathways and their regulatory nodes.
  • Analysis of research on the interplay between Notch signaling, hypoxia, and estrogen in breast cancer.
  • Examination of evidence for functional interactions between HIF-1α, GPER, and Notch signaling.

Main Results:

  • Notch signaling, hypoxia, and estrogen are implicated in driving EMT in breast cancer.
  • A functional interaction exists between hypoxia-inducible factor 1-alpha (HIF-1α) and G protein-coupled estrogen receptor (GPER) in breast cancer cells and CAFs.
  • A proposed functional network involving HIF-1α, GPER, and Notch signaling integrates tumor microenvironmental cues to induce EMT.

Conclusions:

  • The convergence of hypoxia and estrogen signaling on Notch-mediated EMT highlights a complex regulatory network.
  • Further research is needed to elucidate the precise mechanisms of hypoxia and estrogen signaling in Notch-mediated EMT within the tumor microenvironment.
  • The findings suggest potential benefits for pharmacological strategies targeting this network to inhibit breast cancer progression.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.6K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.5K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.4K
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.5K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.9K